Citric Acid as a Potential Prostate Cancer Biomarker Determined in Various Biological Samples
暂无分享,去创建一个
[1] G. Carrieri,et al. Prostate Cancer Radiogenomics—From Imaging to Molecular Characterization , 2021, International journal of molecular sciences.
[2] Zemin Hou,et al. Androgens in prostate cancer: A tale that never ends. , 2021, Cancer letters.
[3] R. Tauler,et al. Untargeted metabolomics of prostate cancer zwitterionic and positively charged compounds in urine. , 2021, Analytica chimica acta.
[4] M. Cooperberg,et al. Biomarkers in Prostate Cancer Diagnosis: From Current Knowledge to the Role of Metabolomics and Exosomes , 2021, International journal of molecular sciences.
[5] M. Matuszewski,et al. Lipidomics as a Diagnostic Tool for Prostate Cancer , 2021, Cancers.
[6] S. Zappavigna,et al. Assessment of Total, PTEN-, and AR-V7+ Circulating Tumor Cell Count by Flow Cytometry in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Enzalutamide. , 2021, Clinical genitourinary cancer.
[7] M. Markuszewski,et al. The potential role of fatty acids in prostate cancer determined by GC-MS analysis of formalin-fixed paraffin-embedded tissue samples. , 2021, Journal of pharmaceutical and biomedical analysis.
[8] A. Sciarra,et al. Tissue Expression of Androgen Receptor Splice Variant 7 at Radical Prostatectomy Predicts Risk of Progression in Untreated Nonmetastatic Prostate Cancer , 2021, Oncology.
[9] Jea-Hyun Baek,et al. Tricarboxylic Acid (TCA) Cycle Intermediates: Regulators of Immune Responses , 2020, Life.
[10] B. Chung,et al. Prospective assessment of two-gene urinary test with multiparametric magnetic resonance imaging of the prostate for men undergoing primary prostate biopsy , 2020, World Journal of Urology.
[11] David A. Bader,et al. Tumour metabolism and its unique properties in prostate adenocarcinoma , 2020, Nature Reviews Urology.
[12] G. Pierantoni,et al. Effects of Long-Term Citrate Treatment in the PC3 Prostate Cancer Cell Line , 2019, International journal of molecular sciences.
[13] L. Porter,et al. Transcriptomics Signature from Next-Generation Sequencing Data Reveals New Transcriptomic Biomarkers Related to Prostate Cancer , 2019, Cancer informatics.
[14] L. O’Neill,et al. A Role for the Krebs Cycle Intermediate Citrate in Metabolic Reprogramming in Innate Immunity and Inflammation , 2018, Front. Immunol..
[15] R. Bertolla,et al. Prostate cancer proteomics: clinically useful protein biomarkers and future perspectives , 2018, Expert review of proteomics.
[16] G. Andriole,et al. Serum cholesterol and risk of high-grade prostate cancer: results from the REDUCE study , 2017, Prostate Cancer and Prostatic Diseases.
[17] R. Mithen,et al. Development of a LC-MS/MS Method for the Simultaneous Detection of Tricarboxylic Acid Cycle Intermediates in a Range of Biological Matrices , 2017, Journal of analytical methods in chemistry.
[18] Z. Husain,et al. Citrate Suppresses Tumor Growth in Multiple Models through Inhibition of Glycolysis, the Tricarboxylic Acid Cycle and the IGF-1R Pathway , 2017, Scientific Reports.
[19] Eric Eidelman,et al. The Metabolic Phenotype of Prostate Cancer , 2017, Front. Oncol..
[20] J. Erikssen,et al. Cholesterol and prostate cancer risk: a long-term prospective cohort study , 2016, BMC Cancer.
[21] L. Pengfei,et al. Cholesterol Levels in Blood and the Risk of Prostate Cancer: A Meta-analysis of 14 Prospective Studies , 2015, Cancer Epidemiology, Biomarkers & Prevention.
[22] M. Hediger,et al. Zinc transporters in prostate cancer. , 2013, Molecular aspects of medicine.
[23] Charles Pound,et al. Identification of Plasma Lipid Biomarkers for Prostate Cancer by Lipidomics and Bioinformatics , 2012, PloS one.
[24] Vincent Goffin,et al. Prolactin regulation of the prostate gland: a female player in a male game , 2011, Nature Reviews Urology.
[25] P. Stattin,et al. 1H HRMAS NMR Derived Bio-markers Related to Tumor Grade, Tumor Cell Fraction, and Cell Proliferation in Prostate Tissue Samples , 2011, Biomarker insights.
[26] M. Djamgoz,et al. Citrate transport in the human prostate epithelial PNT2‐C2 cell line: electrophysiological analyses , 2004, The Journal of physiology.
[27] M. Tan,et al. Role of zinc in the pathogenesis and treatment of prostate cancer: critical issues to resolve , 2004, Prostate Cancer and Prostatic Diseases.
[28] E. Riboli,et al. Plasma prolactin and prostate cancer risk: A prospective study , 2001, International journal of cancer.
[29] R. Franklin,et al. The Intermediary Metabolism of the Prostate: A Key to Understanding the Pathogenesis and Progression of Prostate Malignancy , 2000, Oncology.
[30] Bernhard O. Palsson,et al. Cancer cell lines , 1999 .
[31] P. Facchini,et al. Citrate in urine determined with a new citrate lyase method. , 1995, Clinical chemistry.
[32] A. Heerschap,et al. In vitro proton magnetic resonance spectroscopy of four human prostate cancer cell lines , 1995, The Prostate.
[33] J. Kavanagh. Isocitric and citric acid in human prostatic and seminal fluid: Implications for prostatic metabolism and secretion , 1994, The Prostate.
[34] J. Arunakaran,et al. Effects of prolactin and androgens on the prostatic lipids of castrated mature bonnet monkeys , 1990, The Prostate.
[35] J. F. Cooper,et al. The role of citric acid in the physiology of the prostate: a preliminary report. , 1958, Transactions. American Urological Association. Western Section.
[36] T. Mann,et al. Secretory function of male accessory organs of reproduction in mammals. , 1951, Physiological reviews.